Alliancebernstein L.P. Ocugen, Inc. Transaction History
Alliancebernstein L.P.
- $287 Billion
- Q3 2024
A detailed history of Alliancebernstein L.P. transactions in Ocugen, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 138,730 shares of OCGN stock, worth $101,272. This represents 0.0% of its overall portfolio holdings.
Number of Shares
138,730
Previous 138,730
-0.0%
Holding current value
$101,272
Previous $215,000
36.28%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding OCGN
# of Institutions
125Shares Held
78.4MCall Options Held
535KPut Options Held
523K-
Black Rock Inc. New York, NY17.9MShares$13.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.9MShares$12.4 Million0.0% of portfolio
-
State Street Corp Boston, MA15.8MShares$11.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.28MShares$4.58 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA2.45MShares$1.79 Million0.1% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $158M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...